Skip to main content
All lobbying filings

FARRAGUT PARTNERS LLP

Lobbying for JOHNSON & JOHNSON SERVICES INC · ​Medical and consumers products

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 7
  • SARAH WALTER
    Previously held: Former Legislative Director/Chief Counsel, Sen. John Breaux
  • EDWARD WHITFIELD
    Previously held: U.S. Representative (21 yrs.)
  • KRISTEN BAUTZ
    Previously held: Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz
  • JEFF MACKINNON
    Previously held: LD and LA Rep. Joe Barton (R-Texas)
  • JEFFERY C. MORTIER
    Previously held: Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes
  • DYLAN MOORE
    Previously held: Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); ; Intern, Rep. Mike Turner (OH-10)
  • CONSTANTINE HINGSON New on this filing
    Previously held: Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Medicare/Medicaid

Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation.

Health Issues

Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem